Iovance Biotherapeutics, Inc. announced that Wendy Dixon, Ph.D. who has been a member of Board of Directors since 2022, will not stand for re-election at the Annual Meeting, to be held on June 6, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.02 USD | +0.12% |
|
+0.12% | -1.35% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.35% | 2.24B | |
-42.89% | 8.21B | |
+6.77% | 3.55B | |
-27.06% | 1.86B | |
-21.23% | 1.68B | |
+9.31% | 940M | |
+29.42% | 751M | |
-12.66% | 667M | |
+1.19% | 286M | |
-26.05% | 143M |
- Stock Market
- Equities
- IOVA Stock
- News Iovance Biotherapeutics, Inc.
- Iovance Biotherapeutics, Inc. Announces Wendy Dixon, Member of Board of Directors, Will Not Stand for Re-Election